Yousif Capital Management LLC Sells 1,305 Shares of HCA Healthcare, Inc. $HCA

Yousif Capital Management LLC decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.0% during the 3rd quarter, HoldingsChannel reports. The fund owned 17,249 shares of the company’s stock after selling 1,305 shares during the period. Yousif Capital Management LLC’s holdings in HCA Healthcare were worth $7,352,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Saudi Central Bank bought a new position in HCA Healthcare in the 1st quarter valued at approximately $26,000. WPG Advisers LLC acquired a new position in shares of HCA Healthcare during the first quarter worth $27,000. Ameriflex Group Inc. acquired a new stake in HCA Healthcare in the second quarter valued at $27,000. Chung Wu Investment Group LLC acquired a new position in HCA Healthcare during the 2nd quarter worth about $27,000. Finally, Clearstead Trust LLC increased its stake in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after buying an additional 53 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

HCA stock opened at $474.06 on Thursday. The company has a market cap of $108.18 billion, a P/E ratio of 18.32, a price-to-earnings-growth ratio of 1.40 and a beta of 1.36. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $520.00. The stock’s 50 day simple moving average is $473.53 and its 200 day simple moving average is $418.93.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $412.00 to $431.00 and gave the company an “equal weight” rating in a research report on Thursday, November 13th. Stephens boosted their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Robert W. Baird lifted their price objective on HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Truist Financial raised their target price on HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Finally, Oppenheimer increased their price target on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $479.00.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.